Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells - PubMed (original) (raw)
. 2000 Jan 13;19(2):241-7.
doi: 10.1038/sj.onc.1203263.
Affiliations
- PMID: 10645002
- DOI: 10.1038/sj.onc.1203263
Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells
S W Nam et al. Oncogene. 2000.
Abstract
Autotaxin (ATX), an exo-nucleotide pyrophosphatase and phosphodiesterase, was originally isolated as a potent stimulator of tumor cell motility. In order to study whether ATX expression affects motility-dependent processes such as invasion and metastasis, we stably transfected full-length ATX cDNA into two non-expressing cell lines, parental and ras-transformed NIH3T3 (clone7) cells. The effect of ATX secretion on in vitro cell motility was variable. The ras-transformed, ATX-secreting subclones had enhanced motility to ATX as chemoattractant, but there was little difference in the motility responses of NIH3T3 cells transfected with atx, an inactive mutant gene, or empty vector. In MatrigelTM invasion assays, all subclones, which secreted enzymatically active ATX, demonstrated greater spontaneous and ATX-stimulated invasion than appropriate controls. This difference in invasiveness was not caused by differences in gelatinase production, which was constant within each group of transfectants. In vivo studies with athymic nude mice demonstrated that injection of atx-transfected NIH3T3 cells resulted in a weak tumorigenic capacity with few experimental metastases. Combination of ATX expression with ras transformation produced cells with greatly amplified tumorigenesis and metastatic potential compared to ras-transformed controls. Thus, ATX appears to augment cellular characteristics necessary for tumor aggressiveness.
Similar articles
- Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor.
Nam SW, Clair T, Kim YS, McMarlin A, Schiffmann E, Liotta LA, Stracke ML. Nam SW, et al. Cancer Res. 2001 Sep 15;61(18):6938-44. Cancer Res. 2001. PMID: 11559573 - A sensitive screening assay for secreted motility-stimulating factors.
Nam SW, Clair T, Schiffmann E, Liotta LA, Stracke ML. Nam SW, et al. Cell Motil Cytoskeleton. 2000 Aug;46(4):279-84. doi: 10.1002/1097-0169(200008)46:4<279::AID-CM5>3.0.CO;2-P. Cell Motil Cytoskeleton. 2000. PMID: 10962482 - Expression and transcriptional regulation of the PD-Ialpha/autotaxin gene in neuroblastoma.
Kawagoe H, Stracke ML, Nakamura H, Sano K. Kawagoe H, et al. Cancer Res. 1997 Jun 15;57(12):2516-21. Cancer Res. 1997. PMID: 9192834 - [Significance of serum autotaxin activity in gastrointestinal disease].
Ikeda H, Watanabe N, Nakamura K, Kume Y, Nakai Y, Fujishiro M, Omata M, Igarashi K, Yokota H, Yatomi Y. Ikeda H, et al. Rinsho Byori. 2009 May;57(5):445-9. Rinsho Byori. 2009. PMID: 19522250 Review. Japanese. - Stimulation and regulation of tumor cell motility in invasion and metastasis.
Levine MD, Liotta LA, Stracke ML. Levine MD, et al. EXS. 1995;74:157-79. doi: 10.1007/978-3-0348-9070-0_8. EXS. 1995. PMID: 8527892 Review.
Cited by
- Autotaxin signaling via lysophosphatidic acid receptors contributes to vascular endothelial growth factor-induced endothelial cell migration.
Ptaszynska MM, Pendrak ML, Stracke ML, Roberts DD. Ptaszynska MM, et al. Mol Cancer Res. 2010 Mar;8(3):309-21. doi: 10.1158/1541-7786.MCR-09-0288. Epub 2010 Mar 2. Mol Cancer Res. 2010. PMID: 20197381 Free PMC article. - Lysophosphatidate induces chemo-resistance by releasing breast cancer cells from taxol-induced mitotic arrest.
Samadi N, Bekele RT, Goping IS, Schang LM, Brindley DN. Samadi N, et al. PLoS One. 2011;6(5):e20608. doi: 10.1371/journal.pone.0020608. Epub 2011 May 27. PLoS One. 2011. PMID: 21647386 Free PMC article. - The emerging role of FTY720 (Fingolimod) in cancer treatment.
White C, Alshaker H, Cooper C, Winkler M, Pchejetski D. White C, et al. Oncotarget. 2016 Apr 26;7(17):23106-27. doi: 10.18632/oncotarget.7145. Oncotarget. 2016. PMID: 27036015 Free PMC article. Review. - Novel point mutations attenuate autotaxin activity.
Koh E, Bandle RW, Roberts DD, Stracke ML, Clair T. Koh E, et al. Lipids Health Dis. 2009 Feb 17;8:4. doi: 10.1186/1476-511X-8-4. Lipids Health Dis. 2009. PMID: 19222837 Free PMC article. - Evaluation of the cytotoxicity of the Bithionol-paclitaxel combination in a panel of human ovarian cancer cell lines.
Ayyagari VN, Diaz-Sylvester PL, Hsieh TJ, Brard L. Ayyagari VN, et al. PLoS One. 2017 Sep 20;12(9):e0185111. doi: 10.1371/journal.pone.0185111. eCollection 2017. PLoS One. 2017. PMID: 28931042 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources